MedTrace Logo

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

NCT00643630 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2008-05-22

No results posted yet for this study

Summary

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Conditions

  • Healthy

Interventions

DEVICE

Tetrix

Twice daily topical application

DEVICE

Tetrix

Twice daily topical application

Sponsors & Collaborators

  • Coria Laboratories, Ltd.

    lead INDUSTRY

Principal Investigators

  • Joseph Fowler, MD · Dermatology Specialists

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-10-31
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00643630 on ClinicalTrials.gov